PsychPartnersPsychPartners
 
PsychPartnersPsychPartners
New Patients
  • Locations
    • Providers
    • Locations
  • Self Help
    • Self Help Blog
    • Research for the Public
    • Lifestyle
    • Supplements
    • Psych Meds
    • Pocket Psychiatrist Podcast
    • Depression & Bipolar Workbook
  • Psych Ed
    • Research Updates
      • Full Research (Daily Psych)
      • Top Research
      • LinkedIn
      • Facebook
      • X
      • Bluesky
    • Books
    • Carlat Psych Podcast
    • Talks
  • Join our Team
    • Primary Care Partners
    • Therapy Partners
    • Employment
  • Contact
FDA-Cleared Device for ADHD: New Trial
ADHDChild PsychiatryDisordersNeuromodulation/TMSResearchResearch for the PublicTop Research

FDA-Cleared Device for ADHD: New Trial

November 9, 2026by Chris Aiken, MD0
New Medications at the 2026 APA Meeting
ADHDDementiaDisordersMedicationsResearchSchizophrenia and Psychosis

New Medications at the 2026 APA Meeting

October 27, 2026by Chris Aiken, MD0
JAMA Changes Guidance on eCigs
DisordersResearchResearch for the PublicSubstance Use

JAMA Changes Guidance on eCigs

October 7, 2026by Chris Aiken, MD0
Doctors Pushback on FDA
Research

Doctors Pushback on FDA

August 21, 2026by Chris Aiken, MD0
The FDA Erred with Oxycontin. Here’s the History they Ignored.
DisordersOpioidsResearchResearch for the PublicSubstance Use

The FDA Erred with Oxycontin. Here’s the History they Ignored.

August 17, 2026by Chris Aiken, MD0
FDA Approves New Antidepressant That Does Not Work
AntidepressantsMedicationsResearchTop Research

FDA Approves New Antidepressant That Does Not Work

June 25, 2026by Chris Aiken, MD2
Is Dextromethorphan a Psychedelic?
AntidepressantsDepressionDifficult to Treat DepressionPsychedelicsResearch

Is Dextromethorphan a Psychedelic?

June 16, 2026by Chris Aiken, MD1
Stimulant Misuse Is Declining
ADHDChild PsychiatryCocaineMedicationsResearchStimulantsSubstance Use

Stimulant Misuse Is Declining

June 9, 2026by Chris Aiken, MD0
One Med Stands Out in Re-Analysis of Cocaine Use Disorder
Addiction MedsCocaineMedicationsMethamphetamineResearchSubstance UseTop Research

One Med Stands Out in Re-Analysis of Cocaine Use Disorder

June 8, 2026by Chris Aiken, MD0
FDA Clears a New Type of TMS for PTSD
DevicesDisordersNeuromodulation/TMSPTSDResearchResearch for the PublicTop Research

FDA Clears a New Type of TMS for PTSD

June 7, 2026by Chris Aiken, MD0
FDA Moves the Goalposts on Alcohol Treatment
Addiction MedsAlcoholResearchSubstance Use

FDA Moves the Goalposts on Alcohol Treatment

June 2, 2026by Chris Aiken, MD0
At-Home Device Approved for PTSD
DevicesDisordersNeuromodulation/TMSPTSDResearchResearch for the PublicTop Research

At-Home Device Approved for PTSD

May 28, 2026by Chris Aiken, MD0
Atomoxetine Combo for Sleep Apnea
MedicationsResearchSleepTop Research

Atomoxetine Combo for Sleep Apnea

May 21, 2026by Chris Aiken, MD0
Leucovorin Scripts Surge in Autism
AutismChild PsychiatryMedicationsResearch

Leucovorin Scripts Surge in Autism

May 20, 2026by Chris Aiken, MD0
CBT Helps Sustain Esketamine
DepressionDifficult to Treat DepressionKetamineResearchTherapyTop Research

CBT Helps Sustain Esketamine

May 7, 2026by Chris Aiken, MD0
A GLP-1 Trial Changes the Score in Alcohol, With a Catch
AlcoholGLP1 AgonistsMedicationsResearchResearch for the PublicSubstance UseTop Research

A GLP-1 Trial Changes the Score in Alcohol, With a Catch

May 5, 2026by Chris Aiken, MD0
FDA Approves At-Home tDCS — But Should It Have?
DepressionNeuromodulation/TMSResearch

FDA Approves At-Home tDCS — But Should It Have?

April 25, 2026by Chris Aiken, MD2
Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia
AntipsychoticsBipolar MedsResearchSchizophrenia and PsychosisTop Research

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

March 30, 2026by Chris Aiken, MD3
Flow: At-home tDCS Approved for Depression
DepressionNeuromodulation/TMSResearchResearch for the PublicTop Research

Flow: At-home tDCS Approved for Depression

March 17, 2026by Chris Aiken, MD0
A Wearable Headset for Difficult-to-Treat Depression
DepressionDevicesDifficult to Treat DepressionNeuromodulation/TMSResearchResearch for the PublicTop Research

A Wearable Headset for Difficult-to-Treat Depression

March 15, 2026by Chris Aiken, MD0

Older Posts

Top Studies
All Studies
Self Help
Become a Therapy Partner

Recent Posts

  • November 15, 2026Amphetamine Improves Driving in Young Adults with ADHD

  • November 14, 2026Problems in the Dextromethorphan-Bupropion (Auvelity) Evidence

  • November 14, 2026Expert Guidelines on Dextromethorphan-Bupropion

  • November 14, 2026Meta-analysis Ranks Clomipramine High in OCD

  • November 14, 2026Rethinking ADHD in DSM

Categories

  • Addiction Meds
  • ADHD
  • Alcohol
  • Antidepressants
  • Antipsychotics
  • Anxiety
  • Autism
  • Benzodiazepines
  • Bipolar
  • Bipolar Meds
  • Cannabis
  • Child Psychiatry
  • Clozapine
  • Cocaine
  • Cognition
  • Dementia
  • Deprescribing
  • Depression
  • Devices
  • Difficult to Treat Depression
  • Disorders
  • Eating Disorders
  • ECT
  • Exercise
  • Geriatric Psychiatry
  • GLP1 Agonists
  • Hypnotics
  • Inflammation
  • Ketamine
  • Lifestyle
  • Light Therapy
  • Lithium
  • Med-Psych
  • Medications
  • Methamphetamine
  • Neuromodulation/TMS
  • Nutrition
  • OCD
  • Opioids
  • Personality Disorders
  • Psychedelics
  • PTSD
  • Research
  • Research for the Public
  • Schizophrenia and Psychosis
  • Sedatives
  • Sexual dysfunction
  • Side Effects
  • Sleep
  • Stimulants
  • Substance Use
  • Supplements
  • Therapy
  • Top Research
  • Uncategorized
  • Women's Health
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_02.png?fit=161%2C245&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_03.png?fit=84%2C96&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_10.png?fit=75%2C84&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/SquareLogoMediumThumn-min.jpg?resize=160%2C160&ssl=1

Collaborative mental health

©2025 Psych Partners USA | Terms of use | Cookie policy

Career opportunities
Chris Aiken, MD
LINKS
  • About us
    • Chris Aiken, MD
    • Team
    • Contact
    • Locations
ADMINISTRATIVE TEAM

Nancy Brandon,
Director of Operations

2016 Ashburn Lane
Clemmons, NC 27012

(336) 948-1876

nancy.brandon@psych-partners.com

ADMIN HOURS

Mon – Fri: 9am-5pm EST
Sat – Sun: Closed

bt_bb_section_top_section_coverage_image